µ±Ç°Î»ÖãºÊ×Ò³ > ¶ËÁ£Óë¶ËÁ£Ã¸µÄ·¢ÏÖÀú³Ì - ¼Çŵ±´¶ûÉúÀíѧ»òҽѧ½±
±í´ïÁ˶ËÁ£Ã¸µÄ´ß»¯ÑÇ»ùºÍRNAÑÇ»ù£¬ÔÚÌåÍâÖØ½¨Á˶ËÁ£Ã¸»îÐÔ£¬Ö¤Ã÷ÕâÁ½¸öºËÐÄÑÇ»ùµÄ´æÔÚÊǶËÁ£Ã¸
[23]
»îÐԵıØÐèÇÒÍ걸Ìõ¼þ£¨sufficiency£©¡£
ÖÁ´Ë£¬ÓйØÈ¾É«ÌåÄ©¶ËÒþËõÎÊÌâºÍ±£»¤ÎÊÌâµÄÃÕµ×ÖÕÓÚÈ«²¿½Ò¿ªÁË¡£¶ËÁ£ºÍ¶ËÁ£Ã¸µÄһϵÁз¢ÏÖÍêÃÀµØ½âÊÍÁËÕâÁ½¸öÎÊÌ⣺ȾɫÌåÄ©¶ËµÄDNAÓɼòµ¥Öظ´µÄ¶ËÁ£ÐòÁй¹³É£¬¶ËÁ££¨±¾ÎÄΪÁ˼ò½à³Æ¶ËÁ£DNAΪ¶ËÁ££¬Æäʵ¶ËÁ£µÄ׼ȷ¶¨ÒåÊǶËÁ£DNAºÍ½áºÏµ°°×Ðγɵĸ´ºÏÌ壩±£»¤×ÅȾɫÌåÄ©¶Ë£¬Ê¹Ö®Çø±ðÓÚÒ»°ãµÄ¶ÏÁÑȾɫÌåÄ©¶Ë£¬¶ø²»±»¸÷ÖÖø½µ½â£¬Ï໥֮¼ä²»»áÈںϡ£¶ËÁ£Ã¸¸ºÔð¶ËÁ£µÄ¸´ÖÆ£¬¶ËÁ£Ã¸µÄ´ß»¯ÑÇ»ùÀûÓöËÁ£Ã¸×Ô¼ºµÄRNAÑÇ»ù×÷Ϊģ°åͨ¹ýתλ²»¶ÏÖØ¸´¸´ÖƳö¶ËÁ£DNA£¬´Ó¶ø²¹³¥ÔÚȾɫÌ叴֯¹ý³ÌÖеÄÄ©¶ËÒþËõ£¬±£Ö¤È¾É«ÌåµÄÍêÈ«¸´ÖÆ£¨Í¼Èý£©¡£
ͼÈý
ÕâµÄÈ·ÊǷdz£ÍêÃÀµÄ·¢ÏÖÂó̡£È»¶øÉúÎïÌåÔÚչʾÄÚÔڵļòµ¥ÐÔµÄͬʱ£¬»¹»áÏÔʾ³öËüÄÚÔڵĶàÑùÐԺ͸´ÔÓÐÔ¡£ÐèÒªÖ¸³öµÄÊDZ¾ÎÄÃèÊöµÄÖ»ÊǶËÁ£ºÍ¶ËÁ£Ã¸ÁìÓò·¢ÏÖµÄÖ÷Ïß¡£Êµ¼ÊÉÏ£¬Ï¸°û´©¹ýÒÚÍòÄêµÄʱ¹â£¬ÔÚÂþ³¤µÄ½ø»¯Öг¢ÊÔÁ˸÷ÖÖ¿ÉÄÜÐÔ¡£¶ËÁ£Ã¸¸´ÖÆÖ»ÊÇÆäÖÐÒ»ÖÖ×îΪÆÕ±éµÄ½â¾öȾɫÌåÄ©¶ËÒþËõÎÊÌâµÄ·½Ê½¡£»Øµ½×î³õµÄ²ÂÏ룬µ±Ê±ÈËÃDz²âÍ¬Ô´ÖØ×éÑÓÉì¶ËÁ£µÄ¼Ù˵Ҳ²¢Ã»ÓÐ´í£¬Ï¸°ûʵ¼ÊÉÏÒ²¿ÉÒÔͨ¹ýÍ¬Ô´ÖØ×éµÄ·½Ê½ÑÓÉì¶ËÁ£[24]¡£ÁÑÖ³½Íĸ¿ÉÒÔͨ¹ýȾɫÌåͷβÏàÁª£¬»·»¯µÄ·½Ê½À´±Ü¿ªÈ¾É«ÌåÄ©¶ËÒþËõµÄÎÊÌ⣬ÔÚȱ·¦¶ËÁ£Ã¸ºÍ¶ËÁ£µÄÇé¿öÏÂÉú´æ´«´ú[25]¡£ÕâÓëJames WatsonÌá³öµÄȾɫÌåÁªÌåµÄ²ÂÏëÆÄÓÐÒìÇúͬ¹¤Ö®Ãî¡£¹ûÓ¬ÄÜͨ¹ýת×ù×ӵIJ»¶Ï¸´ÖÆÑÓÉì¶ËÁ£[26]¡£¶ø²¡¶¾¸üÊÇÎÞËù²»ÓÃÆä¼«£¬ËüÃÇÄܹ»ÀûÓõ°°×[27]»òÕßtRNA[28]×÷ΪÒýÎïÀ´Æðʼ»ùÒò×éDNAµÄºÏ³É£¬´Ó¶øÊ¹×Ô¼ºµÄȾɫÌå½â¾ö¸´ÖƵÄÒþËõÎÊÌâ¡£ ²»µÃ²»ÔÞ̾£¬½ø»¯£¬»òÕßÉúÎïÌ壬տÊÇÌì²Å°¡£¡ Time will tell£¨Ê±¼ä½«¸æËßÒ»ÇУ©-Æôʾ
´Ó±¾ÎĵÄÃèÊö¿ÉÒÔ¿´³ö£¬¶ËÁ£ºÍ¶ËÁ£Ã¸×îÖØÒªµÄ·¢ÏÖ¶¼ÊÇÔÚËÄĤ³æ»òÕßÄð¾Æ½ÍĸÕâÁ½¸öµÍµÈµÄģʽÉúÎïÉÏ»ñµÃµÄ¡£Ò»Ð©µÍµÈÉúÎ±ÈÈçÄð¾Æ½ÍĸÔÚÒÅ´«Ñ§²Ù×÷ÉϵÄÏà¶ÔÓÅÊÆ£¬ÓÉÓÚ¼¼ÊõÉϵķ¢Õ¹£¬ÓÈÆäÊÇRNAi¼¼
5 / 8
ÊõÔÚ²¸È鶯Îïϸ°ûÉϵÄÓ¦Óã¬ÒѾÂýÂý±äС¡£µ«ÊÇÕâ¸ö°¸ÀýÈÔȻ˵Ã÷£¬Ä£Ê½ÉúÎïÔÚijÖÖÒâÒåÉÏûÓÐÓÅÁÓÖ®·Ö£¬ÖØÒªµÄÊÇÏë½â¾öµÄÎÊÌâÊÇʲô£¬È»ºóÑ¡Ôñ×î¿ÉÄܻشðÎÊÌâµÄģʽÉúÎï×÷ΪÑо¿²ÄÁÏ¡£
Ëæ×ÅÔ½À´Ô½¼¤ÁҵľºÕù£¬ÏÖÔÚÖйúµÄ¿ÆÑ§½çÀï³äÂúן¡ÔêµÄÆøÏ¢¡£ºÜ¶àµ¼Ê¦ÕûÌì´ß±Æ×ÅѧÉú¹¤×÷£¬¿ìËٵط¢ÎÄÕ£¬ÉêÇë»ù½ð£¬¶øÍüÁË¿ÆÑÐÈËÔ±ÐèÒª¾²ÏÂÐÄÀ´ÔĶÁÎÄÏ׺ÍçÇÃÜ˼¿¼£¬ÕÒ³öÎÊÌâµÄ¹Ø¼ü£¬²¢¶Ô¿ÎÌâ½øÐо«ÐÄÌÖÂÛºÍÉè¼Æ¡£Ñ§ÉúÔÚÕâÖÖ»·¾³Ï³е£×Å·±ÖصÄʵÑéÈÎÎñ£¬Ò²²»Äܳä·ÖÌåÑéµ½×·Öð¿ÆÑ§ÎÊÌâµÄÀÖȤ£¬Öð½¥É¢Ê§ÁË¿ÆÑеÄÖ÷¶¯ÐÔ¡£±¾ÎÄÌṩÁËÒ»¸öºÜºÃµÄ¿ÆÑ§ÎÊÌâÍÆÑݵݸÀý¡£Ëü±íÃ÷£¬ÓÐ˼ÏëµÄ£¬Ô´´ÐԵijɹû²ÅÄÜÕæÕýΪ¿ÆÑ§×ö³ö¹±Ï×£¬²¢×îºóʤ³ö¡£
²»µÃ²»Ëµ£¬ÕâÖÖ¸¡ÔêµÄÆøÏ¢Óë¿ÆÑлù½ðµÄµ¼ÏòÒ²ÃÜÇÐÏà¹Ø¡£ÏÖÔÚµÄÏîÄ¿×ÊÖú¶¼ÒªÇó¿ÆÑÐÓëÖØ´ó¼²²¡¡¢¹ú¼ÆÃñÉú¹Ò¹³¡£µÄÈ·£¬¹«ÖÚÄÉ˰ÈËÓÐͶÈë¾ÍÒª²ú³öµÄÒªÇ󣬶ø¿ÆÑ§µÄÑо¿Ä£Ê½Ò²Ö𽥵شÓÒÔ´¿ºÃÆæÎª¶¯Á¦µÄÑо¿ÑÝ»¯³ÉÒÔÉç»áÐèÇóΪ¶¯Á¦µÄÑо¿¡£µ«ÊÇÕâÒ»Çж¼ÒªÒÔ×ðÖØ¿ÆÑ§×ÔÉíµÄ·¢Õ¹¹æÂÉΪǰÌá¡£
¿ÆÑ§·¢ÏÖµÄÀúÊ·Ò»ÔÙÖØ¸´×ÅÒ»¸öÊÂʵ£¬Ðí¶àΰ´óµÄ·¢ÏÖÀ´×ÔÓÚ¶Ô¿ÆÑ§»ù±¾ÎÊÌâµÄ׷Ѱ£¬¶øÕâÐ©ÖØÒªÎÊÌâµÄ½â¾ö±ØÈ»»áÓÐÔÚµ±Ê±²»ÄܹÀÁ¿µÄÓ¦ÓÃǰ¾°¡£Æ©Èç¶ËÁ£µÄ·¢ÏÖʹÈ˹¤È¾É«ÌåµÃÒÔ·¢Ã÷£¬È˹¤È¾É«ÌåµÄ·¢Ã÷ºóÀ´ÓÖΪ»ùÒò×é²âÐò×ö³öÖØÒª¹±Ïס£Æä´Î£¬»ùÓÚÒÑÓÐ֪ʶµÄÓ¦ÓÃÑо¿¹ÌȻֵµÃ´óÁ¦Ö§³Ö£¬µ«Êǵ±Ç°¶ÔÉúÃü»ù±¾»î¶¯µÄÁ˽⻹ºÜÓÐÏÞ£¬Ò»Î¶µØÍùÓ¦ÓÃÑо¿µ¼ÏòЧ¹ûÒ²²»»áºÜÃ÷ÏÔ¡£
»ù´¡Ñо¿ºÍÓ¦ÓÃÑо¿µÄ¹ØÏµ£¬¾ÍÏñ¸ùÒ¶ºÍ¹ûʵµÄ¹ØÏµ¡£¸ùҶïʢ¶ø²»¿ª»¨½á¹ûµÄÊ÷Ö»ÓйÛÉͼÛÖµ¶øÃ»ÓÐʳÓüÛÖµ¡£µ«ÊǹûʵµÄÑø·Ö¹é¸ù½áµ×À´×ÔÓÚ¸ùÎüÊÕµÄË®·ÝºÍÑøÁÏ£¬ÒÔ¼°Ê÷Ò¶¹âºÏ³ÉµÄÓлúÎï¡£¾¡¹ÜµÀÀídzÏÔ£¬»¹ÊÇÓÐÎÞÖªÎÞηµÄÈËÒòΪ¸ùҶûÓÐʳÓüÛÖµ¶ø²»ÖØÊÓËüÃÇ£¬Ò»Î¶µØÇóÈ¡¹ûʵ¡£Öйú×÷Ϊһ¸ö´ó¹ú£¬ÒÔÉç»áÐèÇóΪ¶¯Á¦µÄÓ¦ÓÃÑо¿£¬ºÍÒÔ½â¾öÔÚ¿ÆÑ§·¢Õ¹ÖгöÏֵĻù±¾ÎÊÌâΪ¶¯Á¦µÄ»ù´¡Ñо¿£¬ÍêÈ«Äܹ»ÇÒÓ¦¸Ã£¬²¢¼ÝÆëÇý£¬ÏàµÃÒæÕá£
×îºóÒÔLizºÍCarolÔÚ2004Äê»ØÒäËýÃÇ·¢ÏÖµÄÒ»¶Î»°×÷Ϊ½áβ¡£\telomerase and health will endure... We did not set out to find a new approach to cancer therapy or study specific disease mechanisms. We were simply interested in how chromosomes are maintained...Yet the history of medicine is filled with examples of advances from improbable places¡£\£¨Ê±¼ä½«¸æËßÈËÃǶËÁ£Ã¸ºÍÈËÀཡ¿µµÄºÎÖÖÁªÏµ²ÅÄܳ־ÃÏÂÈ¥¡¡ÎÒÃÇ×î³õ²¢²»ÊÇ×ÅÊÖÓÚÏëÒªÕÒµ½Ò»¸öеÄÖÎÁư©Ö¢µÄ·½·¨»òÕßÑо¿Ä³¸ö¼²²¡µÄ»úÀí¡¡µ«ÊÇҽѧµÄÀúÊ·³äÂúÁË´Ó²»¿ÉÄܵĵط½»ñµÃÖØ´ó½øÕ¹µÄÀý×Ó¡££©[10] ¸½£º±¾ÎÄÌáµ½µÄ¶ËÁ£ºÍ¶ËÁ£Ã¸·¢ÏÖ´óʼÇ
1939Ä꣬Barbara McClintock·¢ÏÖÓñÃ×ϸ°ûµÄȾɫÌå¶ÏÁÑÄ©¶ËÈÝÒ×ÈÚºÏ 1972Ä꣬James WatsonÌá³öȾɫÌ叴֯µÄÄ©¶ËÒþËõÎÊÌâ 1978Ä꣬±¨µÀËÄĤ³æµÄ¶ËÁ£ÐòÁÐ
1982Ä꣬¶ËÁ£µÄ·¢ÏÖµ¼ÖÂÈ˹¤È¾É«ÌåµÄ·¢Ã÷ 1984Ä꣬±¨µÀ½ÍĸµÄ¶ËÁ£ÐòÁÐ
1985Ä꣬±¨µÀËÄĤ³æµÄ¶ËÁ£Ã¸»îÐÔ
1989Ä꣬±¨µÀËÄĤ³æ¶ËÁ£Ã¸µÄRNAÑÇ»ù 1994Ä꣬±¨µÀ½Íĸ¶ËÁ£Ã¸µÄRNAÑÇ»ù 1995Ä꣬±¨µÀ½Íĸ¶ËÁ£Ã¸»îÐÔ
1996Ä꣬´¿»¯ÁËËÄĤ³æ¶ËÁ£Ã¸µÄ´ß»¯ÑÇ»ù,ÒÅ´«É¸Ñ¡µ½½Íĸ¶ËÁ£Ã¸µÄ´ß»¯ÑÇ»ù 1997Ä֤꣬Ã÷ÁËËÄĤ³æºÍ½Íĸ¶ËÁ£Ã¸µÄ´ß»¯ÑÇ»ù ²Î¿¼ÎÄÏ×
1. Blasco, M.A., Lee, H.W., Hande, M.P., Samper, E., Lansdorp, P.M., DePinho, R.A., and Greider, C.W. (1997). Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34.
2. Neumann, A.A., and Reddel, R.R. (2002). Telomere maintenance and cancer -- look, no telomerase.
6 / 8
Nature reviews 2, 879-884.
3. Watson, J.D. (1972). Origin of concatemeric T7 DNA. Nature: New biology 239, 197-201.
4. McClintock, B. (1939). The Behavior in Successive Nuclear Divisions of a Chromosome Broken at Meiosis. Proceedings of the National Academy of Sciences of the United States of America 25, 405-416. 5. Blackburn, E.H., and Gall, J.G. (1978). A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol 120, 33-53.
6. Szostak, J.W., and Blackburn, E.H. (1982). Cloning yeast telomeres on linear plasmid vectors. Cell 29, 245-255.
7. Shampay, J., Szostak, J.W., and Blackburn, E.H. (1984). DNA sequences of telomeres maintained in yeast. Nature 310, 154-157.
8. Greider, C.W., and Blackburn, E.H. (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413.
9. Greider, C.W., and Blackburn, E.H. (1987). The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51, 887-898.
10. Greider, C.W., and Blackburn, E.H. (2004). Tracking telomerase. Cell 116, S83-86, 81 p following S86.
11. Greider, C.W., and Blackburn, E.H. (1989). A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337, 331-337.
12. Singer, M.S., and Gottschling, D.E. (1994). TLC1: template RNA component of Saccharomyces cerevisiae telomerase. Science 266, 404-409.
13. Cohn, M., and Blackburn, E.H. (1995). Telomerase in yeast. Science 269, 396-400.
14. Lundblad, V., and Szostak, J.W. (1989). A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57, 633-643.
15. Lundblad, V., and Blackburn, E.H. (1990). RNA-dependent polymerase motifs in EST1: tentative identification of a protein component of an essential yeast telomerase. Cell 60, 529-530.
16. Lin, J.J., and Zakian, V.A. (1995). An in vitro assay for Saccharomyces telomerase requires EST1. Cell 81, 1127-1135.
17. Lingner, J., and Cech, T.R. (1996). Purification of telomerase from Euplotes aediculatus: requirement of a primer 3' overhang. Proc Natl Acad Sci U S A 93, 10712-10717.
18. Lendvay, T.S., Morris, D.K., Sah, J., Balasubramanian, B., and Lundblad, V. (1996). Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 144, 1399-1412.
19. Lingner, J., Hughes, T.R., Shevchenko, A., Mann, M., Lundblad, V., and Cech, T.R. (1997). Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276, 561-567.
20. Counter, C.M., Meyerson, M., Eaton, E.N., and Weinberg, R.A. (1997). The catalytic subunit of yeast telomerase. Proceedings of the National Academy of Sciences of the United States of America 94, 9202-9207.
21. Meyerson, M., Counter, C.M., Eaton, E.N., Ellisen, L.W., Steiner, P., Caddle, S.D., Ziaugra, L., Beijersbergen, R.L., Davidoff, M.J., Liu, Q., et al. (1997). hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785-795.
22. Weinrich, S.L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V.M., Holt, S.E., Bodnar, A.G., Lichtsteiner, S., Kim, N.W., Trager, J.B., et al. (1997). Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature genetics 17, 498-502.
23. Kass-Eisler, A., and Greider, C.W. (2000). Recombination in telomere-length maintenance. Trends
7 / 8
in biochemical sciences 25, 200-204.
24. Sadaie, M., Naito, T., and Ishikawa, F. (2003). Stable inheritance of telomere chromatin structure and function in the absence of telomeric repeats. Genes & development 17, 2271-2282.
25. Biessmann, H., and Mason, J.M. (2003). Telomerase-independent mechanisms of telomere elongation. Cell Mol Life Sci 60, 2325-2333.
26. King, A.J., Teertstra, W.R., and van der Vliet, P.C. (1997). Dissociation of the protein primer and DNA polymerase after initiation of adenovirus DNA replication. The Journal of biological chemistry 272, 24617-24623.
27. Litvak, S., Sarih-Cottin, L., Fournier, M., Andreola, M., and Tarrago-Litvak, L. (1994). Priming of HIV replication by tRNA(Lys3): role of reverse transcriptase. Trends in biochemical sciences 19, 114-118. £¨×÷Õßtoptip×¢Ã÷£º±¾ÎÄÊÇ»ùÓÚ¸öÈËÀí½âÀ´ÕûÀíµÄ¶ËÁ£ºÍ¶ËÁ£Ã¸µÄ·¢ÏÖÀúÊ·£¬ÒòΪ֪ʶʱ¼äÓÐÏÞ£¬ÆäÖбØÓÐÆ«²îºÍÃýÎóµÄµØ·½£¬¹Ø¼üÖ®´¦»¹ÊÇÒÔÔʼÎÄÏ×ΪÖ÷¡£±¾ÈËÖ®ËùÒÔ¸ÏÕâÌËŵ±´¶û½±ÈÈ£¬»¨´óÁ¿µÄʱ¼ä½øÐÐÎÄÏ×ÔĶÁºÍÕûÀí£¬ÊÇÒòΪËüÌṩÁËÒ»´Î¼«ºÃµÄÏò¹«ÖÚ´«²¥¿ÆÑ§Ë¼ÏëµÄ»ú»á¡£ÓÉÓÚ¶ËÁ£ºÍ¶ËÁ£Ã¸ÁìÓòµÄһϵÁз¢Ïֹᴩ×Å\·¢ÏÖÏÖÏó/ÎÊÌâ\Ìá³ö¸ÅÄî/Ä£ÐÍ\ʵÑéÑéÖ¤\µÄ˼·£¬ÖØÏÖÕâ¸ö˼·¶Ô¿ÆÑ§¹¤×÷ÕßÊÇÓÐÆô·¢ÒâÒåµÄ¡£±¾ÎÄÒ²ÌṩÁËÒ»¸öºÜºÃµÄ½Ìѧ°¸Àý¡£Îïµ±¾¡ÆäÓ㬻¶Ó×ªÔØ´«²¥¡££©
8 / 8
¹²·ÖÏí92ƪÏà¹ØÎĵµ